The Australian share market has ended its five-day winning streak after the looming threat of tariffs on US car imports ...
A project to replace CHESS, as the clearing and settlement system is known, by blockchain technology began in 2015. The ...
This business is projected to pay impressive dividends in the coming years. The post This ASX dividend stock is projected to pay a yield of over 8% by 2028 appeared first on The Motley Fool Australia.
The ASX 200 stock says this new segment reflects its strategy to expand globally through a capital-light approach, leveraging ...
Many investors define successful investing as beating the market average over the long term. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. Unfortunately, ...
The relief party on the sharemarket seems to be over as Trump tariffs are back in focus, with local shares trading lower ...
These funds could be top picks for Aussie investors next month. Let's see why. The post 3 of the best ASX ETFs to buy in ...
ASX rises, CBA, BHP up 1pc; copper import tariffs look imminent; Vulcan Energy soars; Bellevue considers guidance downgrade; ...
The Australian sharemarket seesawed on Friday as investors remained uneasy amid the local election climate and US President ...
This week’s Bulls N’ Bears ASX Runner of the Week is… Saferoads. The company’s share price rocketed up after it pocketed ...
Australians are increasingly invested in US shares via ASX ETFs, and some providers have just announced their next round of ...
Australian Clinical Labs Limited (ASX:ACL) is a favorite amongst institutional investors who own 62%
Key Insights Significantly high institutional ownership implies Australian Clinical Labs' stock price is sensitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results